1/37
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
Which structural feature is responsible for rapid COMT metabolism?
The catechol (3,4-dihydroxy) moiety
specifically metabolizes catechol rings.
COMT
Which modification increases membrane retention and duration of action?
Increasing the lipophilicity (LogP) by adding a large lipophilic aralkyl group
___ = more membrane retention = longer duration (e.g., ___).
Higher LogP
salmeterol
Regarding SAR of indirect sympathomimetics
N-substituents larger than a methyl group generally render the compound inactive.
decrease indirect activity.
Large N-substituents
Why is phenoxybenzamine irreversible?
Formation of a reactive aziridinium ion that covalently bonds to the receptor
Why is tamsulosin uroselective?
It shows greater selectivity for the α1A receptor subtype found in the prostate.
What structural modification distinguishes propranolol?
The insertion of an oxymethylene bridge between the aromatic ring and the ethanolamine side chain
Which β1-selective blocker potentiates nitric oxide?
Nebivolol
Comparing carvedilol and labetalol
Carvedilol and labetalol both block α1, β1, and β2 receptors, and only the S-enantiomer of carvedilol has β-blocking activity, while both enantiomers contribute to α1 blockade.
Effect of adding an α-methyl group to phenethylamine?
prevents metabolism by MAO and enhances displacement of norepinephrine.
Why is isoproterenol non-selective?
It acts equally on both β1 and β2 adrenergic receptors.
Drug used in hypertensive emergencies because of an extremely short half-life?
Esmolol
Significance of the aryloxypropanolamine pharmacophore?
provides higher potency and greater beta-blocking activity compared to arylethanolamines.
Phentolamine is
A non-selective, reversible alpha-antagonist.
Primary clinical utility of dobutamine?
a selective β1 agonist that increases cardiac output with minimal peripheral vasoconstriction.
Which β-blocker exhibits intrinsic sympathomimetic activity (ISA)?
Pindolol
Non-selective β-agonist rapidly metabolized by COMT.
Isoproterenol
Selective β1 agonist that increases cardiac output.
Dobutamine
Prototype non-selective β-blocker.
Propranolol
Extremely short half-life due to hydrolysis by RBC esterases.
Esmolol
Quinazoline blocker selective for α1A receptors in the prostate.
Alfuzosin
Irreversible α-antagonist forming an aziridinium ion.
Phenoxybenzamine
β1-selective blocker that potentiates nitric oxide.
Nebivolol
Drug distinguished by insertion of an oxymethylene bridge.
Propranolol
Non-selective irreversible α-antagonist.
Phenoxybenzamine
Acts equally on β1 and β2 receptors.
Isoproterenol
β1-selective blocker ideal for continuous IV infusion.
Esmolol
α1-blocker that relaxes prostatic smooth muscle.
Tamsulosin (Alfuzosin and Silodosin also fit)
Non-selective β-blocker used as the benchmark for potency.
Propranolol
Selective β1 agonist used to treat shock.
Dobutamine
Agent whose effects persist long after the drug is cleared.
Phenoxybenzamine
Third-generation β-blocker with vasodilatory benefit plus β1 antagonism.
Nebivolol
Non-selective β-agonist with poor oral bioavailability because of COMT metabolism.
Isoproterenol
β-blocker with a unique metabolic pathway involving hydrolysis.
Esmolol
Preferred drug for BPH because it minimizes systemic cardiovascular effects.
Tamsulosin
Non-selective β-agonist producing significant cardiac stimulation.
Isoproterenol